Search Login Register
Anti-Arrhythmia Agents
Summary
Description:
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Also Known As:
Anti-Arrhythmia Drugs; Anti-Arrhythmics; Antiarrhythmia Agents; Antiarrhythmia Drugs; Antiarrhythmic Drugs Show All >>
Networked: 1964
relevant articles (175 outcomes,
241 trials/studies)
for this Bio-Agent
Key Diseases for which Anti-Arrhythmia Agents is
Relevant
-
Atrial Fibrillation
:
58 outcomes 59 studies in 412 results
-
Cardiac Arrhythmias (Arrythmia)
:
34 outcomes 57 studies in 373 results
-
Ventricular Tachycardia
:
30 outcomes 27 studies in 264 results
-
Tachycardia (Tachyarrhythmias)
:
29 outcomes 25 studies in 263 results
-
Ventricular Fibrillation
:
9 outcomes 12 studies in 87 results
Show All >>
Drugs Related to Anti-Arrhythmia Agents
-
Amiodarone (Amiodarona)
-
Ion Channels (Ion Channel)
-
Flecainide (Tambocor)
-
Lidocaine (Xylocaine)
-
Sotalol (Sotalol Hydrochloride)
-
Disopyramide (Norpace)
-
Calcium
-
Encainide
-
Quinidine (Chinidin)
-
Bepridil (Vascor)
Show All >>
Therapies Related to Anti-Arrhythmia Agents
-
Electric Countershock (Cardioversion)
-
Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
-
Drug Therapy (Chemotherapy)
-
Ligation
-
Defibrillators (Defibrillator)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.